Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)

Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

(2012) Robert W. Frenck et al.   Clinical and Vaccine Immunology

Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

(2012) P. R. Paradiso   CLINICAL INFECTIOUS DISEASES

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)

(2012) Mark Sanford   DRUGS

Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

(2012) Elizabeth A. Clutterbuck et al.   JOURNAL OF INFECTIOUS DISEASES

Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years

(2012) Derek Weycker et al.   VACCINE

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults

(2011) Robert W Frenck et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

(2011) T.F. Schwarz et al.   VACCINE

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

(2010) Sean T. Duggan   DRUGS

Clinical and economic burden of pneumonia among adults in Latin America

(2010) Raul E. Isturiz et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

(2009) Tom van der Poll et al.   LANCET

Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection

(2008) Lisa A. Jackson et al.   CLINICAL INFECTIOUS DISEASES